709 related articles for article (PubMed ID: 20036327)
1. Insulin and hyperandrogenism in women with polycystic ovary syndrome.
Baptiste CG; Battista MC; Trottier A; Baillargeon JP
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):42-52. PubMed ID: 20036327
[TBL] [Abstract][Full Text] [Related]
2. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
3. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
Nestler JE
Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
[TBL] [Abstract][Full Text] [Related]
4. Massive Ovarian Growth in a Woman With Severe Insulin-Resistant Polycystic Ovary Syndrome Receiving GnRH Analogue.
Singh P; Agress A; Madrigal VK; Magyar C; Ostrzega N; Chazenbalk GD; Dumesic DA
J Clin Endocrinol Metab; 2019 Jul; 104(7):2796-2800. PubMed ID: 30759233
[TBL] [Abstract][Full Text] [Related]
5. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome.
Goudas VT; Dumesic DA
Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
[TBL] [Abstract][Full Text] [Related]
7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovaries and obesity.
Messinis IE; Messini CI; Anifandis G; Dafopoulos K
Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):479-88. PubMed ID: 25487256
[TBL] [Abstract][Full Text] [Related]
9. Role of cytochrome P450c17 in polycystic ovary syndrome.
Qin KN; Rosenfield RL
Mol Cell Endocrinol; 1998 Oct; 145(1-2):111-21. PubMed ID: 9922107
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
[TBL] [Abstract][Full Text] [Related]
11. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
12. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in PCOS.
Diamanti-Kandarakis E
Endocrine; 2006 Aug; 30(1):13-7. PubMed ID: 17185787
[TBL] [Abstract][Full Text] [Related]
14. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
[TBL] [Abstract][Full Text] [Related]
15. PCOS in adolescence and type 2 diabetes.
Carreau AM; Baillargeon JP
Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
[TBL] [Abstract][Full Text] [Related]
16. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment.
Zhao H; Zhang J; Cheng X; Nie X; He B
J Ovarian Res; 2023 Jan; 16(1):9. PubMed ID: 36631836
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance.
Huang-Doran I; Kinzer AB; Jimenez-Linan M; Thackray K; Harris J; Adams CL; de Kerdanet M; Stears A; O'Rahilly S; Savage DB; Gorden P; Brown RJ; Semple RK
J Clin Endocrinol Metab; 2021 Jul; 106(8):2367-2383. PubMed ID: 33901270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
